Recombinant Human Serum Albumin/Interferon alpha-2b Fusion Protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Serum Albumin/Interferon alpha-2b Fusion Protein, covering 2017-05-08 to 2017-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers [Phase 1]